Longitudinal analysis of systemic inflammatory biomarkers in glioblastoma patients: an exploratory single‑center analysis

Key Points

• The central aim is to evaluate the patterns of systemic inflammatory biomarkers in glioblastoma patients and their association with prognosis.
• Conducted a longitudinal analysis of biomarkers in glioblastoma patients at a single center
• Prospectively collected data which includes patient inflammatory profiles
• Characterized tumor molecularly to correlate with biomarker levels
• Identified a higher inflammatory burden associated with poorer prognosis in glioblastoma patients
• Patterns of systemic inflammatory biomarkers may indicate disease progression
• Suggests a need for further studies in larger, molecularly characterized cohorts